Each of the eight people who will be participating in the Boston Marathon in support of the UMass ALS Cellucci Fund has a unique connection to former Gov. Paul Cellucci, to the disease that took his life last year, or to the institution that he believed would find a cure.
Jean A. King, PhD, has been appointed to the new position of associate provost for biomedical science research, in which she will develop the overall vision for and advancement of basic science research at UMMS.
The Surviving and Thriving: Aids, Politics, and Culture exhibit was developed and produced by the National Library of Medicine and is on display until April 26 in the Lamar Soutter Library. A complementary panel discussion featuring UMMS AIDS researchers and clinicians will take place on Tuesday, April 22.
A synthetic luciferin developed by Stephen C. Miller, PhD, shows that fruit flies are secretly harboring the biochemistry needed to glow in the dark—otherwise known as bioluminescence. This discovery expands the scope of bioluminescence imaging for research, and adds new tools for the noninvasive studying of ongoing biological processes.
Chancellor Michael F. Collins promised former Gov. Paul Cellucci that he would continue UMass Medical School’s search for a cure for ALS in the days before Cellucci lost his life to the disease last June, according to a report on Charter TV 3’s Worcester News Tonight.
--UMMS ALS research fund renamed to honor Paul Cellucci
The UMass ALS Champion Fund, which the late Gov. Paul Cellucci helped establish, will be renamed “UMass ALS Cellucci Fund.” The fund is a movement to drive awareness of and funding for the ALS breakthroughs happening at UMMS and in the laboratory of Robert H. Brown Jr., DPhil, MD, one of the world’s leading ALS researchers.
Men considering prostate cancer screening should receive a brief, basic message about the possible benefits and harms of the prostate-specific antigen (PSA) blood test, according to a new recommendation from the Massachusetts Prostate Cancer Screening Guideline Panel, which was spearheaded by UMass Medical School’s Roger Luckmann, MD.
A National Library of Medicine-funded project aims to build a stronger community of women’s health researchers at UMass Medical School by improving and promoting access to women’s health resources, with the ultimate goal of helping women secure academic leadership positions.
MassBiologics received a $5 million grant from the Massachusetts Life Sciences Center to support construction of a viral vector manufacturing facility, the first of its kind in Massachusetts. In this video, Executive Vice Chancellor Mark Klempner explains the therapeutic potential of viral vectors and why MassBiologics was chosen to receive this grant.
Gynecologist Debra Papa discusses the Food and Drug Administration advisory committee’s approval of the Roche HR HPV test as primary screen for cervical cancer. She explains why—and what more needs to be done—in this Expert’s Corner.